Fetal Megakaryocytic Dyshemopoiesis in Down Syndrome: Association with Hepatic and Pancreatic Fibrosis

References

• Ruchelli E D, Uri A, Dimmick J E, et al. Severe perinatal liver disease and Down syndrome: An apparent relationship. Hum Pathol 1991; 22: 1274–80
   PubMed Web of Science ®Google Scholar
• Becroft D MO, Zwi L J. Perinatal visceral fibrosis accompanying the megakaryoblastic leukemoid reaction of Down syndrome. Pediatr Pathol 1990; 10: 397–406
   PubMedGoogle Scholar
• Zipursky A, Peeters M, Poon A. Megakaryoblastic leukemia and Down's syndrome—a review. Prog Clin Biol Res 1987; 246: 33–56
   PubMedGoogle Scholar
• Moniz C F, Nicolaides K H, Bamforth F J, Rodeck C H. Normal reference ranges for biochemical substances relating to renal, hepatic, and bone function in fetal and maternal plasma throughout pregnancy. J Clin Pathol 1985; 38: 468–72
   PubMedGoogle Scholar
• Nicolaides K H, Clewell W H, Mibashan R S, Soothill P W, Rodeck C H, Campbell S. Fetal haemoglobin measurement in the assessment of red cell isoimmunisation. Lancet 1988; 1: 1073–5
   PubMed Web of Science ®Google Scholar
• Nicolaides K H, Thilaganathan B, Mibashan R S. Cordocentesis in the investigation of fetal erythropoiesis. Am J Obstet Gynecol 1989; 161: 1197–200
   PubMed Web of Science ®Google Scholar
• Weiner C P, Sipes S L, Wenstrom K. The effect of fetal age upon normal fetal laboratory values and venous pressure. Obstet Gynecol 1992; 79: 713–8
   PubMed Web of Science ®Google Scholar
• Chan W C, Carroll A, Alvarado C S, et al. Acute megakaryoblastic leukemia in infancy with t(1; 22) (p13;q13) abnormality. Am J Clin Pathol 1992; 98: 214–21
   PubMed Web of Science ®Google Scholar
• Coulombel L, Deryke M, Villeval J L, et al. Characterization of the blast cell population in two neonates with Down's syndrome and transient myeloproliferative disorder. Br J Haematol 1987; 66: 69–76
   PubMed Web of Science ®Google Scholar
• Suda J, Eguchi M, Ozawa T, et al. Platelet peroxidase-positive blast cells in transient myeloproliferative disorder with Down's syndrome. Br J Haematol 1988; 68: 181–7
   PubMed Web of Science ®Google Scholar
• Bessho F, Hayashi Y, Ohga K. Ultrastructural studies of peripheral blood of neonates with Down's syndrome and transient abnormal myelopoiesis. Am J Clin Pathol 1988; 89: 627–33
   PubMed Web of Science ®Google Scholar
• Cantu-Rajnoldi A, Cattoretti G, Caccamo M L, et al. Leukaemoid reaction with megakaryocytic features in newborns with Down's syndrome. Eur J Haematol 1988; 40: 403–9
   PubMedGoogle Scholar
• Sartori P C, Darbyshire P J. Transient myeloproliferative disorder in Down syndrome: Three cases with megakaryocytic markers. Pediatr Hematol Oncol 1991; 8: 139–45
   PubMed Web of Science ®Google Scholar
• Miyashita T, Asada M, Fujimoto J, et al. Clonal analysis of transient myeloproliferative disorder in Down's syndrome. Leukemia 1991; 5: 56–9
   PubMed Web of Science ®Google Scholar
• Eguchi M, Sakakibara H, Suda J, et al. Ultrastructural and ultracytochemical differences between transient myeloproliferative disorder and megakaryoblastic leukaemia in Down's syndrome. Br J Haematol 1989; 73: 315–22
   PubMed Web of Science ®Google Scholar
• Raney R B. Transient myeloproliferative disorder in a neonate with Down syndrome. Clin Pediatr 1990; 29: 547
   Google Scholar
• Kurahashi H, Hara J, Yumara-Yagi K, et al. Monoclonal nature of transient abnormal myelopoiesis in Down's syndrome. Blood 1991; 77: 1161–3
   PubMed Web of Science ®Google Scholar
• Zipursky A, Doyle J, Christensen H, DeHarven E, Freedman M H. Leukemic cells in the transient leukemia of Down syndrome. Blood 1992; 80(Suppl 1)32a
   Google Scholar
• Kojima S, Matsuyama T, Sato T, et al. Down's syndrome and acute leukemia in childhood: An analysis of phenotype by use of monoclonal antibodies and electron microscopic platelet peroxidase reaction. Blood 1990; 76: 2348–53
   PubMed Web of Science ®Google Scholar
• Gaedicke G, Kleihauer E, Terinde R. Acute non-lymphocytic leukaemia versus transient leukaemoid reaction in fetuses with Down syndrome. Lancet 1990; 1: 857
   Google Scholar
• Zerres K, Schwanitz G, Niesen M, Gembruch U, Hansmann M, Waldherr R. Prenatal diagnosis of acute non-lymphoblastic leukaemia in Down syndrome. Lancet 1990; 1: 117
   Google Scholar
• Foucar K, Friedman K, Llewellyn A, et al. Prenatal diagnosis of transient myeloproliferative disorder via percutaneous umbilical blood sampling: Report of two cases in fetuses affected by Down's syndrome. Am J Clin Pathol 1992; 97: 584–90
   PubMed Web of Science ®Google Scholar
• Tsuda T, Komiyama A, Aonuma K, Akabane T, Nakayama M. Transient abnormal myelopoiesis and diffuse hepatic necrosis in Down's syndrome with prominent bleeding diathesis. Acta Paediatr Scand 1990; 79: 241–4
   PubMed Web of Science ®Google Scholar
• Roberts A B, Mitchell J M, Pattison N S. Fetal liver length in normal and isoimmunized pregnancies. Am J Obstet Gynecol 1989; 161: 42–6
   PubMed Web of Science ®Google Scholar
• Singer D B, Sung C J, Wigglesworth J S. Fetal growth and maturation, with standards for body and organ development. Textbook of Fetal and Perinatal Pathology, J S Wigglesworth, D B Singer. Blackwell Scientific Publications, Boston 1991; Vol. 1: 11–45
   Google Scholar